NDC 49281-405

FLUZONE High-Dose

Influenza A Virus A/michigan/45/2015 X-275 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/singapore/infimh-16-0019/2016 Ivr-186 (h3n2) Antigen (formaldehyde Inactivated), And Influenza B Virus B/maryland/15/2016 Bx-69a (a B/colorado/6/2017-like Virus) Antigen (formaldehyde Inactivated)

FLUZONE High-Dose is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Sanofi Pasteur Inc.. The primary component is Influenza A Virus A/brisbane/02/2018 Ivr-190 (h1n1) Antigen (formaldehyde Inactivated); Influenza A Virus A/kansas/14/2017 X-327 (h3n2) Antigen (formaldehyde Inactivated); Influenza B Virus B/maryland/15/2016 Bx-69a Antigen (formaldehyde Inactivated).

Product ID49281-405_2a088f4a-0535-4385-922f-2b74a04a8bf4
NDC49281-405
Product TypeVaccine
Proprietary NameFLUZONE High-Dose
Generic NameInfluenza A Virus A/michigan/45/2015 X-275 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/singapore/infimh-16-0019/2016 Ivr-186 (h3n2) Antigen (formaldehyde Inactivated), And Influenza B Virus B/maryland/15/2016 Bx-69a (a B/colorado/6/2017-like Virus) Antigen (formaldehyde Inactivated)
Dosage FormInjection, Suspension
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2019-07-01
Marketing End Date2020-06-30
Marketing CategoryBLA / BLA
Application NumberBLA103914
Labeler NameSanofi Pasteur Inc.
Substance NameINFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED)
Active Ingredient Strength60 ug/.5mL; ug/.5mL; ug/.5mL
NDC Exclude FlagN

Packaging

NDC 49281-405-65

10 SYRINGE, GLASS in 1 PACKAGE (49281-405-65) > .5 mL in 1 SYRINGE, GLASS (49281-405-88)
Marketing Start Date2019-07-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 49281-405-65 [49281040565]

FLUZONE High-Dose INJECTION, SUSPENSION
Marketing CategoryBLA
Application NumberBLA103914
Product TypeVACCINE
Billing UnitML
Marketing Start Date2019-07-01
Marketing End Date2020-06-30

NDC 49281-405-88 [49281040588]

FLUZONE High-Dose INJECTION, SUSPENSION
Marketing CategoryBLA
Application NumberBLA103914
Product TypeVACCINE
Billing UnitML
Marketing Start Date2019-07-01
Marketing End Date2020-06-30

Drug Details

NDC Crossover Matching brand name "FLUZONE High-Dose" or generic name "Influenza A Virus A/michigan/45/2015 X-275 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/singapore/infimh-16-0019/2016 Ivr-186 (h3n2) Antigen (formaldehyde Inactivated), And Influenza B Virus B/maryland/15/2016 Bx-69a (a B/colorado/6/2017-like Virus) Antigen (formaldehyde Inactivated)"

NDCBrand NameGeneric Name
49281-403FLUZONE High-DoseINFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/Maryland/15/2016 BX-69A (a B/Colorado/6/2017-like virus) ANTIGEN (FORMALDEHYDE INACTIVATED)
49281-405FLUZONE High-DoseINFLUENZA A VIRUS A/Michigan/45/2015 X-275 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/Maryland/15/2016 BX-69A (a B/Colorado/6/2017-like virus) ANTIGEN (FORMALDEHYDE INACTIVATED)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.